VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,020,369 | -9.2% | 483,849 | +1.6% | 1.60% | -6.6% |
| Q2 2023 | $14,332,471 | -6.4% | 476,004 | +0.5% | 1.71% | -8.7% |
| Q1 2023 | $15,315,127 | +10.8% | 473,420 | -1.8% | 1.87% | +3.8% |
| Q4 2022 | $13,816,347 | +17.2% | 482,078 | -1.4% | 1.80% | +10.6% |
| Q3 2022 | $11,788,000 | +18.1% | 488,717 | +34.1% | 1.63% | +19.4% |
| Q2 2022 | $9,981,000 | -33.7% | 364,533 | -7.1% | 1.36% | -21.0% |
| Q1 2022 | $15,056,000 | +21.2% | 392,592 | +1.2% | 1.73% | +25.9% |
| Q4 2021 | $12,427,000 | +27.0% | 387,976 | +16.8% | 1.37% | +20.9% |
| Q3 2021 | $9,788,000 | +4.1% | 332,122 | +20.0% | 1.13% | +3.7% |
| Q2 2021 | $9,403,000 | +11.7% | 276,729 | +6.9% | 1.09% | +4.0% |
| Q1 2021 | $8,415,000 | -21.9% | 258,922 | -13.5% | 1.05% | -26.4% |
| Q4 2020 | $10,776,000 | +0.1% | 299,165 | +8.9% | 1.43% | -15.5% |
| Q3 2020 | $10,761,000 | +13.5% | 274,794 | +6.3% | 1.69% | +6.7% |
| Q2 2020 | $9,484,000 | – | 258,556 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |